Mariam Ashraf Buckowski, MD
Family Practice · Tulare
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 5
- Since medical school
- 9 years
- Graduated 2017
Offices
5 locations · Kaweah Delta Health Care District · Community Health Partners · Valley Hospitalist Medical Group, Inc
Hospitals listed: Kaweah Health Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Buckowski’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A174159 · Current
Licensed to practise in California · since 2021 · expires 2027-07-31 · Ross University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 89.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Kaweah Health Medical CenterVisalia, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Kaweah Delta Health Care DistrictPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsWorse than the national rate — Death rate among surgical inpatients with serious treatable complications: 239.86 (194.11 to 285.6) · 104 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.393, Oct 2024 – Sep 2025
See every measure and the patient survey for Kaweah Health Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 3 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 239.86 (194.11 to 285.6) · 104 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.393 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.22 (0.28 to 2.16) · 1,600 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.53 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.4 · 145 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.7 · 226 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 285 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 14.8 · 626 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.1 · 741 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.7 · 373 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 3,927 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.27 (0.08 to 0.46) · 9,045 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.19 (0.01 to 0.38) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.72 (1.81 to 5.63) · 2,251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.07 (0.53 to 3.61) · 768 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.79 (0.45 to 3.13) · 2,231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.88 (1.1 to 12.66) · 799 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.59 (0 to 7.19) · 759 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 416 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.35 (0 to 0.89) · 8,159 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 43 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.728 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.405 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.023 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.551 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 344 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 799 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17 · 286 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 31.4 · 686 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -6 · 734 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.4 · 776 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.6 to 7.6) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.9 (6.6 to 11.9) · 202 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 32 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.6 · 142 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 317 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 10.8 (8.3 to 14) · 1,748 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 680 cases | No different | Jan 2024 – Dec 2024 |
What patients said (435 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 48% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$28,968
Medicare paid this office $28,968 for 151 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 97 | $17,994 | $61 |
| Hospital discharge day management, 30 minutes or less | 73 | $5,000 | $63 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 30 | $2,895 | $97 |
| Return visit (30+ min) | 18 | $1,962 | $73 |
Who their Medicare patients are
151 Original Medicare patients in 2024. Average age 74 · Under 65 15% · 85 and older 22% · Women 47% · Also on Medicaid 54% · Health risk score 2.56. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 75% · Diabetes 54% · Coronary heart disease 51% · Heart failure 46% · Chronic kidney disease 44% · Atrial fibrillation 36% · Depression 34% · COPD 33% · Stroke 26% · Dementia 21% · Cancer 20%.
The office billed $89,253, Medicare allowed $38,149 and paid $28,968; for 449 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 151 | 449 | 74 | 2.56 | $89,253 | $28,968 |
| 2023 | 190 | 458 | 69 | 2.73 | $88,910 | $27,044 |
| 2022 | 260 | 495 | 65 | 1.85 | $99,196 | $26,492 |
| 2021 | 152 | 206 | 63 | 1.62 | $27,311 | $11,844 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 87 | $16,829 | $63 |
| Hospital discharge day management, 30 minutes or less | 66 | $4,597 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $2,689 | $100 |
| Short return visit (20+ min) | 61 | $1,627 | $25 |
2022: 6 services
| Short return visit (20+ min) | 161 | $10,847 | $46 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 26 | $4,773 | $57 |
| Return visit (30+ min) | 48 | $3,978 | $78 |
| Telephone medical discussion with physician, 11-20 minutes | 40 | $2,164 | $47 |
| Hospital discharge day management, 30 minutes or less | 22 | $1,326 | $58 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,290 | $108 |
2021: 1 service
| Short return visit (20+ min) | 125 | $8,653 | $54 |
Medicaid work
$197,525 in 2024
Medicaid paid $197,525 for 1,613 billed services this clinician did in 2024, up to 115 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 617 | $162,941 |
| Return visit (30+ min) | 422 | $16,301 |
| Short return visit (20+ min) | 451 | $15,457 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 81 | $1,888 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 42 | $938 |
| 2024 | 1,613 | 5 | 115 | $197,525 |
| 2023 | 2,736 | 13 | 183 | $182,233 |
| 2022 | 1,544 | 12 | 145 | $23,293 |
| 2021 | 83 | 2 | 21 | $1,738 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 555 | $141,689 |
| Short return visit (20+ min) | 1,026 | $19,114 |
| Return visit (30+ min) | 664 | $16,643 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 177 | $3,684 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 25 | $552 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use | 15 | $304 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 52 | $187 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 22 | $32 |
| Hemoglobin; glycosylated (A1C) by device cleared by FDA for home use | 21 | $30 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 74 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 23 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 49 | $0 |
2022
| Short return visit (20+ min) | 709 | $15,335 |
| Return visit (30+ min) | 149 | $4,911 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 98 | $2,428 |
| Hospital inpatient or observation discharge day management; 30 minutes or less on the date of the encounter | 19 | $395 |
| Short return visit | 13 | $225 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 212 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 28 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 168 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 96 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 23 | $0 |
| Hospital outpatient clinic visit for assessment and management of a patient | 13 | $0 |
2021
| Short return visit (20+ min) | 46 | $1,738 |
| Hospital outpatient clinic visit for assessment and management of a patient | 37 | $0 |
Drugs they prescribed that Part D paid
$138,091
Pharmacies billed $138,091 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 1% of their Part D prescriptions (11 of 1,052) in 2024. At or below the middle of the specialty; the typical family practice clinician is at 2%.
854 generic and 184 brand-name prescriptions · $138,091 in drug cost · 34 antibiotic prescriptions to 29 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 15 | $19,343 | $1,290 |
| Ozempic | 12 | $14,501 | $1,208 |
| Jardiance | 11 | $14,352 | $1,305 |
| Diclofenac | 18 | $12,801 | $711 |
| Eliquis | 15 | $11,846 | $790 |
See all 26 drugs
| Mounjaro | 15 | $19,343 | $1,290 |
| Ozempic | 12 | $14,501 | $1,208 |
| Jardiance | 11 | $14,352 | $1,305 |
| Diclofenac | 18 | $12,801 | $711 |
| Eliquis | 15 | $11,846 | $790 |
| Gabapentin | 30 | $585 | $20 |
| Atorvastatin | 90 | $546 | $6 |
| Estradiol | 11 | $498 | $45 |
| Levothyroxine | 36 | $322 | $9 |
| Fluticasone Propionate | 28 | $263 | $9 |
| Albuterol Sulfate Hfa | 11 | $221 | $20 |
| Tamsulosin | 13 | $193 | $15 |
| Omeprazole | 23 | $175 | $8 |
| Lisinopril | 39 | $174 | $4 |
| Losartan | 23 | $171 | $7 |
| Metformin | 25 | $156 | $6 |
| Montelukast | 11 | $153 | $14 |
| Duloxetine | 12 | $145 | $12 |
| Metoprolol | 15 | $124 | $8 |
| Rosuvastatin | 11 | $114 | $10 |
| Escitalopram | 20 | $112 | $6 |
| Metformin Hcl Er | 12 | $111 | $9 |
| Amlodipine Besylate | 36 | $103 | $3 |
| Carvedilol | 13 | $72 | $6 |
| Metoprolol | 16 | $63 | $4 |
| Furosemide | 17 | $33 | $2 |
Year by year
| 2024 | 1,052 | 276 | 1% (11) | 17% | $138,091 |
| 2023 | 1,085 | 235 | 2% (21) | 16% | $137,635 |
| 2022 | 460 | 117 | None | 16% | $45,429 |
| 2021 | 167 | 53 | None | None | $13,559 |
| 2020 | 135 | 22 | 0% (0) | 16% | $3,576 |
| 2019 | 38 | 12 | 0% (0) | None | $850 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 22 drugs
| Jardiance | 23 | $29,810 | $1,296 |
| Atorvastatin | 105 | $1,404 | $13 |
| Duloxetine | 24 | $907 | $38 |
| Albuterol Sulfate Hfa | 12 | $704 | $59 |
| Gabapentin | 39 | $648 | $17 |
| Levothyroxine | 27 | $523 | $19 |
| Lisinopril | 46 | $502 | $11 |
| Losartan | 29 | $441 | $15 |
| Alendronate | 14 | $372 | $27 |
| Metformin | 26 | $352 | $14 |
| Amlodipine Besylate | 34 | $310 | $9 |
| Omeprazole | 14 | $255 | $18 |
| Hydrochlorothiazide | 13 | $212 | $16 |
| Allopurinol | 11 | $199 | $18 |
| Escitalopram | 11 | $171 | $16 |
| Hydrocodone-Acetaminophen | 17 | $160 | $9 |
| Hydroxyzine | 13 | $130 | $10 |
| Carvedilol | 15 | $124 | $8 |
| Fluticasone Propionate | 16 | $123 | $8 |
| Pantoprazole | 21 | $99 | $5 |
| Furosemide | 17 | $86 | $5 |
| Propranolol | 11 | $84 | $8 |
2022: 7 drugs
| Atorvastatin | 37 | $554 | $15 |
| Losartan | 19 | $386 | $20 |
| Escitalopram | 19 | $215 | $11 |
| Metformin | 19 | $188 | $10 |
| Tamsulosin | 12 | $185 | $15 |
| Lisinopril | 16 | $142 | $9 |
| Alendronate | 12 | $99 | $8 |
2021: 3 drugs
| Tradjenta | 11 | $5,036 | $458 |
| Alendronate | 12 | $54 | $4 |
| Lisinopril | 11 | $40 | $4 |
2020: 2 drugs
| Levothyroxine | 12 | $170 | $14 |
| Lisinopril | 23 | $105 | $5 |
Money from drug and device companies
$38 in 2025
| 2025 | 2 | 2 | None | $38 |
| 2024 | 2 | 2 | None | $130 |
| 2023 | 4 | 4 | None | $102 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $19 | 1 payment
|
| Pfizer | Prevnar 20 | $19 | 1 payment
|
See all 2 published payments
| Pfizer | Meals · 2025-11-20 | Prevnar 20 | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-22 | Airsupra | $19 |
See earlier years (2024, 2023)
2024: $130
| Alexion Pharmaceuticals | Ultomiris | $109 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $21 | 1 payment
|
2023: $102
| NuSmile | Zarc Files | $37 | 1 payment
|
| Dynavax Technologies | Heplisav-B | $25 | 1 payment
|
| Janssen Pharmaceuticals | Xarelto | $24 | 1 payment
|
| Exact Sciences | Cologuard Collection Kit | $16 | 1 payment
|
Professional record
- NPI
- 1801386800
- Licence
- CA A174159California A174159: Current · expires 2027-07-31
- Group
- Kaweah Delta Health Care District · Community Health Partners · Valley Hospitalist Medical Group, Inc
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 1000 N Mooney Blvd, Tulare, CA, 93274
- NPI first listed
- 2018-05-15
- NPI last updated
- 2025-08-22
- NPI record certified
- 2025-08-22
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 400 W Mineral King Ave, Visalia, CA, 93291